Market Research Logo

Ophthalmic Devices Market Analysis By Product (Diagnostics & Monitoring Devices, Fundus Camera, Optical Coherence Tomography Scanner, Retinoscope, Tonometer, Pachymeter Ophthalmoscope, Biometer, Autorefractor, Surgical Instruments, Refractive Error Surger

Ophthalmic Devices Market Analysis By Product (Diagnostics & Monitoring Devices, Fundus Camera, Optical Coherence Tomography Scanner, Retinoscope, Tonometer, Pachymeter Ophthalmoscope, Biometer, Autorefractor, Surgical Instruments, Refractive Error Surgery Devices, Glaucoma Surgery Devices, Cataract & Vitreoretinal Surgery Devices, Vision Care Products, Contact Lenses, Spectacle Lenses) And Segment Forecasts To 2024

The global ophthalmic devices market is expected to reach USD 55.5 billion by 2024, according to a new report by Grand View Research, Inc. The rising geriatric population base is presumed to propel the need for ophthalmic devices as this age group is more prone towards the development of chronic eye disorders. The rising prevalence of eye disorders such as macular degeneration, cataract, diabetic retinopathy and glaucoma is also boosting the growth of ophthalmic devices.

Approximately 10% of the people suffering from eye disorders will experience loss of vision in spite of the proper treatment as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Additionally, the rising demand for minimally invasive and complication-free operative surgeries is expected to upsurge the demand for ophthalmic devices.

The ophthalmic devices market growth can also be attributed to technological advancements such as the development of intraocular lenses, mydriatic fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. For instance, in May 2016, Bausch & Lomb through its enterprise partnership with Apple and IBM will develop a cataract surgery app that would integrate patient data, calculation data, and records thereby helping cataract surgeons’ work efficiently. The app will be enabled with IBM’s cognitive computing capabilities to reduce surgical errors.

Further key findings from the study suggest:

The vision care segment dominated the product segment of the overall ophthalmic devices market in terms of revenue share at over 78.0%in 2015,owing to its adoption in vision correction procedures and the rising number of initiatives to promote the awareness pertaining to vision care

For instance, in April 2016, Alcon announced its support to the “Think About Your Eyes”, which is a public awareness program. Alcon committed USD 4 million to support this initiative to promote the awareness pertaining to vision care

The diagnostic& monitoring devices segment is expected to grow at the fastest CAGR at over 7.0% in 2015. This can be attributed to the fact that diagnosis is an indispensable process in the treatment of eye disorders and is responsible for contributing towards the diagnostics & monitoring segment’s growth

In 2015, North America dominated the overall ophthalmic devices market at over 36.0%owing to the increasing utilization of ophthalmic devices in hospitals and private clinics. Moreover, subsequent changes in demographic trends, such as a rise in the geriatric population & unhealthy lifestyles, are presumed to drive the market in this region. Moreover, high R&D investments in the development of new products are expected to impel the market growth in North America

Asia Pacific is anticipated to be growing at the fastest CAGR of around 7.0% over the forecast period due to the presence of untapped opportunities in the emerging economies in China and India. Moreover, the increasing government initiatives towards healthcare infrastructure; for instance, in China, healthcare reforms through an initiative called New Health Care Reform Plan implemented by the Chinese State Council and the Communist Party of China (CPC) Central Committee is expected to drive growth of the Chinese regional market.

Some key players in this market are involved in adopting collaborative strategies and indulge in frequent product approvals to facilitate business and geographical expansions. For instance, in February 2016, Alcon acquired Transcend Medical, Inc., in a probe to expand its business in the treatment of glaucoma. This acquisition added Minimally Invasive Glaucoma Surgical (MIGS) devices to Alcon’s product portfolio.


Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Ophthalmic devices market - Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Ophthalmic Devices Industry Outlook
3.1. Ophthalmic Devices Market Segmentation
3.2. Ophthalmic Devices Market Size and Growth Prospects
3.3. Ophthalmic Devices market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing prevalence of eye disorders
3.3.1.2. Technological advancements
3.3.1.3. Rapid technological advancements
3.3.1.4. Rising awareness pertinent to ophthalmic diseases
3.3.2. Market Restraint Analysis
3.3.2.1. Risk associated with eye surgery
3.4. Key Opportunities Prioritized
3.5. Ophthalmic devices Competitive Landscape, 2015
3.5.1. Company Market Share Analysis, 2015
3.5.2. Competitive Landscape: Market Position Analysis (based on products, regional presence, and strategic initiatives)
3.6. Industry Analysis - Porter's
3.7. Ophthalmic Devices Market PESTEL Analysis, 2015
Chapter 4. Ophthalmic Devices Product Outlook
4.1. Ophthalmic devices Market Share By Product, 2015 & 2024
4.2. Diagnostics & Monitoring Devices
4.2.1. Diagnostics & Monitoring Devices Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.1.1. Fundus Camera Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.1.2. Optical Coherence Tomography Scanner Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.1.3. Retinoscope Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.1.4. Tonometer Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.1.5. Pachymeter Ophthalmoscope Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.1.6. Biometer Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.1.7. Autorefractor Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.2. Surgical Instruments
4.2.2.1. Surgical Instruments Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.2.2. Refractive Error Surgery Devices Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.2.3. Glaucoma Surgery Devices Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.2.4. Cataract & Vitreoretinal Surgery Devices Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.3. Vision Care Products
4.2.3.1. Vision Care Products Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.3.2. Contact Lenses Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.3.3. Spectacle Lenses Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 5. Ophthalmic Devices Regional Outlook
5.1. Ophthalmic devices Market Share By Region, 2015 & 2024
5.2. North America
5.2.1. North America Market Estimates and Forecasts, By Product, 2013 - 2024 (USD Million)
5.2.1.1. U.S. Market Estimates and Forecasts
5.2.1.2. Canada Market Estimates and Forecasts
5.3. Europe
5.3.1. Europe Market Estimates and Forecasts, By Product, 2013 - 2024 (USD Million)
5.3.1.1. UK Market Estimates and Forecasts
5.3.1.2. Germany Market Estimates and Forecasts
5.4. Asia Pacific
5.4.1. Asia Pacific Market Estimates and Forecasts, By Product, 2013 - 2024 (USD Million)
5.4.1.1. Japan Market Estimates and Forecasts
5.4.1.2. China Market Estimates and Forecasts
5.4.1.3. India Market Estimates and Forecasts
5.5. Latin America
5.5.1. Latin America Market Estimates and Forecasts, By Product, 2013 - 2024 (USD Million)
5.5.1.1. Brazil Market Estimates and Forecasts
5.5.1.2. Mexico Market Estimates and Forecasts
5.6. MEA
5.6.1. MEA Market Estimates and Forecasts, By Product, 2013 - 2024 (USD Million)
5.6.1.1. South Africa Market Estimates and Forecasts
Chapter 6. Competitive Landscape
6.1. Abbott Medical Optics Inc.
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. Carl Zeiss Meditec AG
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Alcon Inc.
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Bausch & Lomb, Inc.
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Haag-Streit
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Topcon Corporation
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives’
6.7. Johnson & Johnson
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Essilor International S.A.
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. Nidek Co. Ltd.
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Ziemer Ophthalmic Systems AG
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report